Jack Nathan Medical Corp.
JNH.V
TSX
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 143.90% | -182.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 143.90% | -182.97% | |||
| Cost of Revenue | 128.31% | -220.11% | |||
| Gross Profit | 149.53% | -174.63% | |||
| SG&A Expenses | 157.94% | -176.69% | |||
| Depreciation & Amortization | 109.50% | -246.77% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 147.84% | -186.54% | |||
| Operating Income | -161.16% | 201.30% | |||
| Income Before Tax | -134.04% | 229.95% | |||
| Income Tax Expenses | 321.92% | -- | |||
| Earnings from Continuing Operations | -141.08% | 227.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -107.93% | 762.76% | |||
| EBIT | -161.16% | 201.30% | |||
| EBITDA | -156.51% | 232.35% | |||
| EPS Basic | -107.89% | 762.91% | |||
| Normalized Basic EPS | -134.15% | 230.85% | |||
| EPS Diluted | -107.97% | 756.29% | |||
| Normalized Diluted EPS | -133.87% | 244.19% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.38% | -9.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||